These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10515417)

  • 1. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
    Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
    Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
    PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia].
    Suga M; Iyonaga K; Ando M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():175-80. PubMed ID: 9216211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia.
    Kuwano K; Kawasaki M; Maeyama T; Hagimoto N; Nakamura N; Shirakawa K; Hara N
    Chest; 2000 Aug; 118(2):451-8. PubMed ID: 10936140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical significance of mast cell tryptase in bronchial alveolar lavage fluid in interstitial lung diseases].
    Kawatani K; Kondo M; Tamaoki J; Tagaya E; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):848-55. PubMed ID: 18051786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
    Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
    Front Immunol; 2020; 11():562564. PubMed ID: 33101280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia.
    Yoshioka S; Mukae H; Sugiyama K; Kakugawa T; Sakamoto N; Nakayama S; Abe K; Fujii T; Kadota J; Kohno S
    Respir Med; 2004 Oct; 98(10):945-51. PubMed ID: 15481270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases.
    Kodama N; Yamaguchi E; Hizawa N; Furuya K; Kojima J; Oguri M; Takahashi T; Kawakami Y
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):526-31. PubMed ID: 9533940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia.
    Dobashi N; Fujita J; Ohtsuki Y; Yamadori I; Yoshinouchi T; Kamei T; Takahara J
    Eur Respir J; 1999 Sep; 14(3):574-8. PubMed ID: 10543277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
    Chen F; Shu XM; Wang DX; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.